Cargando…
Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
PURPOSE: To report the results of the Single Fraction Early Prostate Irradiation (SiFEPI) phase 2 prospective trial. MATERIALS/METHODS: The SiFEPI trial (NCT02104362) evaluated a single fraction of high-dose rate brachytherapy (HDB) for low- (LR) and favorable-intermediate (FIR) risk prostate cancer...
Autores principales: | Hannoun-Levi, Jean-Michel, Chand-Fouche, Marie-Eve, Pace-Loscos, Tanguy, Gautier, Mathieu, Gal, Jocelyn, Schiappa, Renaud, Pujol, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449500/ https://www.ncbi.nlm.nih.gov/pubmed/36093342 http://dx.doi.org/10.1016/j.ctro.2022.08.007 |
Ejemplares similares
-
High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort
por: Marotte, Delphine, et al.
Publicado: (2022) -
High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes
por: le Guyader, Maud, et al.
Publicado: (2021) -
10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2022) -
High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis
por: Martz, Nicolas, et al.
Publicado: (2021) -
Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes
por: Hijazi, Hussam, et al.
Publicado: (2013)